SynAct Pharma AB 8F8.F Stock
SynAct Pharma AB Price Chart
SynAct Pharma AB 8F8.F Financial and Trading Overview
| SynAct Pharma AB stock price | 0.62 EUR |
| Previous Close | 6.12 EUR |
| Open | 6.3 EUR |
| Bid | 6.42 EUR x N/A |
| Ask | 6.66 EUR x N/A |
| Day's Range | 6.3 - 6.3 EUR |
| 52 Week Range | 3.63 - 8.33 EUR |
| Volume | 11 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 202.1M EUR |
| Beta (5Y Monthly) | 0.649425 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.51 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8F8.F Valuation Measures
| Enterprise Value | 199.52M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 9.692308 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
SynAct Pharma AB Stock Price History
| Beta (5Y Monthly) | 0.649425 |
| 52-Week Change | 56.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.33 EUR |
| 52 Week Low | 3.63 EUR |
| 50-Day Moving Average | 6.28 EUR |
| 200-Day Moving Average | 5.89 EUR |
8F8.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 31.82M |
| Float | 23.15M |
| Short Ratio | N/A |
| % Held by Insiders | 34.03% |
| % Held by Institutions | 2.59% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.12% |
| Return on Equity (ttm) | -95.74% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 0.68 EUR |
| Current Ratio (mrq) | 3.815 |
| Book Value Per Share (mrq) | 0.65 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of SynAct Pharma AB
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | Scheelevägen 2 |
| ZIP | 223 81 |
| Phone | 45 28 44 75 67 |
| Website | https://synactpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
SynAct Pharma AB, a clinical stage biotechnology company, engages in the research and development of medicines for the treatment of inflammatory diseases. It is developing AP1189, a drug candidate for the treatment of rheumatoid arthritis, idiopathic membranous nephropathy, and virus-induced respiratory insufficiency. The company also develops TXP-11, an advanced peptide agonist that is in preclinical trials for the prevention of organ failures in complicated surgery; and various drug programs to treat auto-immune diseases. The company was founded in 2012 and is headquartered in Lund, Sweden.
Q&A For SynAct Pharma AB Stock
What is a current 8F8.F stock price?
SynAct Pharma AB 8F8.F stock price today per share is 0.62 EUR.
How to purchase SynAct Pharma AB stock?
You can buy 8F8.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SynAct Pharma AB?
The stock symbol or ticker of SynAct Pharma AB is 8F8.F.
Which industry does the SynAct Pharma AB company belong to?
The SynAct Pharma AB industry is Biotechnology.
How many shares does SynAct Pharma AB have in circulation?
The max supply of SynAct Pharma AB shares is 42.6M.
What is SynAct Pharma AB Price to Earnings Ratio (PE Ratio)?
SynAct Pharma AB PE Ratio is now.
What was SynAct Pharma AB earnings per share over the trailing 12 months (TTM)?
SynAct Pharma AB EPS is -0.51 EUR over the trailing 12 months.
Which sector does the SynAct Pharma AB company belong to?
The SynAct Pharma AB sector is Healthcare.